206 related articles for article (PubMed ID: 105012)
1. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
3. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
4. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
6. HLA/Bf haplotypes in a Newfoundland family.
Larsen B; Pepper B; Barnard JM; Farid NR
Tissue Antigens; 1978 Jul; 12(1):39-43. PubMed ID: 581240
[TBL] [Abstract][Full Text] [Related]
7. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
[TBL] [Abstract][Full Text] [Related]
8. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.
Mackay IR; Tait BD
Gastroenterology; 1980 Jul; 79(1):95-8. PubMed ID: 7380229
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
10. HLA haplotypes in familial Graves' disease.
Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
12. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Nagataki S
Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
[TBL] [Abstract][Full Text] [Related]
13. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
[TBL] [Abstract][Full Text] [Related]
14. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
[TBL] [Abstract][Full Text] [Related]
15. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
16. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
17. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
Lacka K; Kordel M; Gembicki M
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
[TBL] [Abstract][Full Text] [Related]
18. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
[TBL] [Abstract][Full Text] [Related]
19. [HLA DRW3 and Graves' disease (author's transl)].
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
[TBL] [Abstract][Full Text] [Related]
20. [HLA B8 and Graves' disease (author's transl)].
Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
